Navigation Links
Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team
Date:3/31/2016

PROVIDENCE, R.I., March 31, 2016 /PRNewswire/ -- Genomics firm Nabsys has completed a financial  restructuring under the leadership of founding CEO, Barrett Bready, M.D., who returned to the company in October 2015. In addition, members of the original technical leadership team, including Chief Technology Officer, John Oliver, Ph.D., Executive Vice President of Product Development, Steve Nurnberg and Vice President of Software and Informatics, Michael Kaiser have returned to the company.

Dr. Bready served as CEO of Nabsys from 2005-2014 and raised $50 million to develop the company's high definition electronic DNA mapping platform. In early 2015, under different leadership, the company pivoted to a different and ultimately unsuccessful technical approach. Dr. Bready returned to Nabsys in October 2015, recruited back the technical leadership team and has re-focused the company on its core technology.

Nabsys has developed semiconductor-based nanodetectors to analyze very long DNA molecules electronically, at high velocity and with much greater resolution than offered by optical approaches. This technology allows researchers, and will ultimately allow clinicians, to draw conclusions about DNA that would be difficult or impossible with other technologies. 

"I'm grateful that all members of our technical leadership team have returned to Nabsys in recent months," said Bready. "The fact that we were able to get the team organized so quickly meant that very little time was lost during this transition period. The past six months have been the most productive in the company's history."

John Oliver, Ph.D., added, "The Nabsys platform is incredibly powerful when applied to the right challenges and has an unprecedented ability to scale. We are excited to once again be exploring the potential of this technology as a team and anticipate sharing our progress in the near future."

About Nabsys
Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a "1000 Genome" award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genomics-firm-nabsys-completes-financial-restructuring-and-reinstates-technical-leadership-team-300243783.html


'/>"/>
SOURCE Nabsys
Copyright©2016 PR Newswire.
All rights reserved


Related biology news :

1. Newborn Screening Ontario Inks Deal with Tute Genomics, UNIConnect Team to Deliver Informatics Infrastructure for NGS Testing
2. Rubicon Genomics Announces Eurofins Scientific Will Distribute Its Suite of DNA Library Preparation Kits in U.S.
3. Den 10. internationale konference om Genomics (ICG-10) åbner i oktober
4. La 10e International Conference on Genomics (ICG-10) doit souvrir en octobre
5. La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre
6. The 10th International Conference on Genomics (ICG-10) to Open in October
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. ACT Genomics Raises $8 Million in its First Private Funding Round
9. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
10. The Genome Institute at Washington University Receives Irys System from BioNano Genomics to Advance Research for Genome Reference Consortium
11. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2018)... , ... December 14, 2018 , ... ... number 9,703,929 entitled “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by the ... of October 21, 2014. The patent is an invention by uBiome collaborators Dr. ...
(Date:12/13/2018)... ... December 12, 2018 , ... New research by Florida Polytechnic University faculty ... and distracted driving, one of the main causes of car accidents and fatalities on ... Kanwal Gagneja , assistant professor of computer science, uses a microcomputer, a camera, and ...
(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings ... TN, from December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an ... the treatment continuum – from the consultation, to surgical planning, and into the ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... 08, 2019 , ... The American Society of Gene and Cell Therapy’s ... selection committee made up of industry leaders identified by the ASGCT board of directors. ... awards created to support ASGCT members designing transformative pilot studies in gene and cell ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the leading ... industry, unveiled a completely redesigned website at http://www.usdm.com . The site offers ... their valued clients and business partners. , The website has a revamped ...
(Date:12/13/2018)... , ... December 12, 2018 , ... Helping conclude Healthy ... new sleek and slim hearing aid within its Vision and Hearing campaign that sets ... , Studies show that despite continued efforts to destigmatize hearing aids over the ...
Breaking Biology Technology: